1. 808PNon-metastatic castration-resistant prostate cancer (nmCRPC): Meta-analysis of efficacy and safety with novel hormonal agents apalutamide and enzalutamide. (23rd October 2018) Authors: Almeida, D V P; de Oliveira, C Z; Mariano, R C; Kater, F R; Souza, M C L A; Ruiz-Schutz, V C; Yamamura, R; Saraiva De Carvalho, R; Maluf, F C; Morgans, A K; Srinivas, S; Gupta, S; Dorff, T; Yu, E Y; Schutz, F A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗